Arix to present at HC Wainwright on 10 April

RNS Number : 8704J

Arix Bioscience Plc

05 April 2018

 

Arix Bioscience to present at H.C. Wainwright & Co. Global Life Sciences Conference on 10 April 2018

LONDON, 5 April 2018: Arix Bioscience plc (LSE: ARIX) ("Arix Bioscience") a global healthcare and life science company supporting medical innovation, announces that Joe Anderson, CEO, will present at the H.C. Wainwright & Co. Global Life Sciences Conference on 10 April 2018, at 11.30 CEST at the Le Meridien Beach Plaza Hotel in Monte Carlo, Monaco.

A webcast of the presentation will be accessible live and available to replay on Arix's website at https://arixbioscience.com/presentations.

Ends

For more information on Arix, please contact:

Arix Bioscience plc

Charlotte Parry, Investor Relations Manager

[phone]

[e-mail]

Consilium Strategic Communications

Mary-Jane Elliott, Jessica Hodgson, Ivar Milligan

[phone]

[e-mail]

About Arix Bioscience plc

Arix Bioscience plc is a global healthcare and life science company supporting medical innovation. Headquartered in London and with an office in New York, Arix Bioscience sources, finances and builds world class healthcare and life science businesses addressing medical innovation at all stages of development. Operations are supported by privileged access to breakthrough academic science and strategic relationships with leading research accelerators and global pharmaceutical companies.

Arix Bioscience plc is listed on the Main Market of the London Stock Exchange. For further information, please visit www.arixbioscience.com

 

END

 

 

NRASSLFMLFASELL